ePrints

Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome (APDS) in people 12 years and over.

Lookup NU author(s): Nicole O'ConnorORCiD, Dr Hangjian WuORCiD, Oleta WilliamsORCiD, Dr Cristina Fernandez-GarciaORCiD, Sola AkinboladeORCiD, Ayomikun OgunyemiORCiD, Sonia Garcia Gonzalez-MoralORCiD, Fiona BeyerORCiD, Dr Sarah RiceORCiD, Dr Nick MeaderORCiD

Downloads

Full text is not currently available for this publication.

Publication metadata

Author(s): O'Connor N, Wu H, Williams O, Fernandez-Garcia C, Akinbolade S, Ogunyemi A, Gonzalez-Moral SG, Beyer F, Rice S, Meader N

Publication type: Report

Publication status: Published

Series Title: Highly specialised technologies guidance

Year: 2025

Pages: 32

Online publication date: 25/04/2025

Acceptance date: 25/04/2025

Report Number: HST33

Institution: National Institute for Health and Care Excellence

Place Published: Manchester

URL: https://www.nice.org.uk/guidance/HST33

Notes: Produced by Newcastle NIHR Technology Assessment Review (TAR) Team, Newcastle University. [ID6130]. ISBN 9781473169395.

Share